WHO: Updates on Method Transfer

Recommendation
Tuesday, 23 September 2025 13.00 - 17.00 h
In 2022, the WHO published the "Technical Report Series 1044, 2022" called "TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing" on the subject of technology transfer. The previous document dates back to 2011 and has now been updated.
The new annex consists of the following chapters and subsections and also lists an appendix 1:
Background
Abbreviations
1. Introduction
2. Scope
3. Glossary
4. Due diligence and gap analysis
5. Organization and management
6. Quality management and quality risk management
7. Documentation
8. Premises
9. Equipment and instruments
10. Qualification and validation
11. Life cycle approach
12. Phases of a technology transfer project
Phase I: Project initiation
Phase II: Project planning
Phase III: Project transfer execution
Production (example: finished pharmaceutical product)
Quality control: analytical procedure transfer
Cleaning
Phase IV: Project review and close-out
References
Appendix 1 Documentation commonly required for technology transfer
Chapter 12 "Phases of a technology transfer project" under "Quality control: analytical procedure transfer" and Appendix 1 deal specifically with the topic of method transfer.
Annex 4 "TRS 1044 - Annex 4: WHO guidelines on technology transfer in pharmaceutical manufacturing" is available on the WHO website.
Related GMP News
14.07.2025Inadequate Sampling and Component Testing Highlighted in FDA Warning Letter
14.07.2025EMA publishes new Product-Specific Bioequivalence Guidance
14.07.2025Revision of USP Chapter <1039> Chemometrics Published for Comments
14.07.2025Proposal for new USP Chapter <318> NMR Monomer Ratio Determination for Lactide-Glycolide Polymers
14.07.2025New USP Chapter <1221> on Ongoing Procedure Performance Verification (OPPV) Published for Comment
02.07.2025FDA Warning Letter: Missing Testing, No Stability Data, and Inadequate Raw Material Controls